Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mouse model of Friedreich's ataxia (FA) measurably halted cellular damage caused by the degenerative disease.
Original Article: Single infusion of wildtype HSPCs halts cellular damage caused by neuromuscular disorder in mice
NEXT ARTICLE